EARLY BREAST CANCER
Clinical trials for EARLY BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new EARLY BREAST CANCER trials appear
Sign up with your email to follow new studies for EARLY BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New targeted drug combo aims to shrink tumors before surgery, spare patients harsh chemo
Disease control Not yet recruitingThis study is testing a new combination of two targeted drugs, SHR-A1811 and pertuzumab, given before surgery for a specific type of breast cancer that is both hormone receptor-positive (HR+) and HER2-positive. The goal is to see if this approach can effectively shrink or elimina…
Matched conditions: EARLY BREAST CANCER
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC
-
Why do cancer patients quit Life-Saving drugs? new study investigates
Disease control Not yet recruitingThis study aims to understand why patients with early-stage, high-risk breast cancer stop taking their powerful new combination medications too soon. Researchers will follow 81 patients who are prescribed a standard hormone therapy pill plus a newer drug (like abemaciclib or ribo…
Matched conditions: EARLY BREAST CANCER
Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Could a simple test spare thousands of young women from harsh chemo?
Disease control Not yet recruitingThis study aims to see if a genetic test can safely guide treatment decisions for younger women with a common type of early breast cancer. It will compare the standard approach of giving chemotherapy to everyone against a personalized plan where some women receive only hormone th…
Matched conditions: EARLY BREAST CANCER
Phase: PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated Mar 03, 2026 14:05 UTC
-
Massive 100,000-Patient review aims to predict breast Cancer's return
Knowledge-focused Not yet recruitingThis study looks back at the medical records of 100,000 Korean patients with a common type of early-stage breast cancer. The goal is to understand how often the cancer comes back after initial treatment and which factors influence that risk. Researchers will analyze data from pat…
Matched conditions: EARLY BREAST CANCER
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC